Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 362.30 | 241.08 | 350.29 | 296.48 |
Depreciation/ Depletion | 143.60 | 150.19 | 108.11 | 77.20 |
Non- Cash Items | 125.80 | 135.72 | 135.03 | 89.50 |
Changesin Working Capital | -96.30 | -70.96 | -146.74 | -65.03 |
Cashfrom Operating Activities | 535.40 | 456.03 | 446.69 | 398.15 |
Capital Expenditures | -57.50 | -44.57 | -476.14 | -59.59 |
Other Investing Cash Flow Items Total | 33.20 | -242.74 | 26.90 | -152.43 |
Cashfrom Investing Activities | -24.30 | -287.31 | -449.25 | -212.02 |
Financing Cash Flow Items | -29.40 | -37.87 | -30.39 | -15.85 |
Total Cash Dividends Paid | -201.20 | -103.01 | -116.66 | -99.48 |
Issuance( Retirement)of Stock Net | 3.50 | 0.87 | 0.14 | 0.30 |
Issuance( Retirement)of Debt Net | -186.80 | -143.18 | 283.37 | -23.53 |
Cashfrom Financing Activities | -413.90 | -283.18 | 136.45 | -138.56 |
Net Changein Cash | 97.20 | -114.46 | 133.90 | 47.58 |
Cash Interest Paid | 29.40 | 37.72 | 30.39 | 15.84 |
Cash Taxes Paid | 132.00 | 106.43 | 130.03 | 101.70 |
Dr. Lal Pathlabs Dividend Dr. Lal Pathlabs Bonus Dr. Lal Pathlabs News Dr. Lal Pathlabs AGM Dr. Lal Pathlabs Rights Dr. Lal Pathlabs Splits Dr. Lal Pathlabs Board Meetings Dr. Lal Pathlabs Key Metrics Dr. Lal Pathlabs Shareholdings Dr. Lal Pathlabs Profit Loss Dr. Lal Pathlabs Balance Sheet Dr. Lal Pathlabs Q1 Results Dr. Lal Pathlabs Q2 Results Dr. Lal Pathlabs Q3 Results Dr. Lal Pathlabs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks